title: Metronomic schedule of paclitaxel is effective in hormone receptor-positive and hormone receptor-negative breast cancer.
authors.forename: Rita S
authors.initials: RS
authors.lastname: Mehta
authors.forename: Donna
authors.initials: D
authors.lastname: Jackson
authors.forename: Toni
authors.initials: T
authors.lastname: Schubbert
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage*; D011987:Receptors, Steroid / Q000032:analysis*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D011987:Receptors, Steroid; D017239:Paclitaxel